Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background We retrospectively compared the accuracy of somatostatin receptor scintigraphy (SRS) with that of helical computed tomography (CT) in the detection and localization of primary and metastatic neuroendocrine tumors. Methods A medical record search identified 27 patients with known or clinically suspected neuroendocrine tumors who underwent helical CT and SRS within 3 months of one another at our institution. CT images were evaluated retrospectively by two blinded radiologists who used consensus reading. Images were evaluated for the presence or absence of primary tumor and hepatic and extrahepatic metastases. CT results were compared with the SRS report as interpreted by the nuclear medicine physicians. The results of the surgical, clinical follow-up, and pathologic findings were considered as the gold standard. Sensitivity, specificity, and accuracy were calculated for both imaging techniques. In addition, McNemar analysis was performed to determine statistically significant differences between CT and SRS. Results Helical CT was more sensitive than SRS in the detection of extrahepatic metastases, and the difference between the two imaging modalities was statistically significant (p = 0.0312) as determined by the McNemar chi-square test. However, the difference between CT and SRS in detecting primary neuroendocrine tumors, hepatic metastasis, and combined hepatic and extrahepatic metastasis was not statistically significant (p = 0.625, 1.000, and 1.000, respectively)…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Somatostatin receptor scintigraphy is reported to detect insulinomas in approximately half of affected patients (74), although a sensitivity of 80% has been reported (75).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [75]
Citations
Cites
PEARSE, A. G. E. (1969) · Journal of Histochemistry & Cytochemistry · doi:10.1177/17.5.303 · Cited by 1,673 · cited 1×
“more typically referred to as neuroendocrine tumors [1], and”
BackgroundKrenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564 · cited 1×
“In our study, SRS had a high sensitivity of 90% in detecting hepatic metastasis, similar to that reported in the literature [6, 19, 24] but higher than the 50% detection rate reported by Krenning et al. [ 26 ].”
ResultMultisection CT: Scanning Techniques and Clinical Applications
Rydberg, J., Buckwalter, K. A., Caldemeyer, K. S., Phillips, M. D., Conces, D. J., Aisen, A. M., Persohn, S. A., & Kopecky, K. K. (2000) · RadioGraphics · doi:10.1148/radiographics.20.6.g00nv071787 · Cited by 363
Valls, C., Andía, E., Sánchez, A., Gumà, A., Figueras, J., Torras, J., & Serrano, T. (2001) · Radiology · doi:10.1148/radiology.218.1.r01dc1155 · Cited by 259
Lebtahi, R., Cadiot, G., Sarda‐Mantel, L., Daou, D., Faraggi, M., Petegnief, Y., Mignon, M., & Guludec, D. L. (1997) · PubMed · Cited by 240
Chiti, A., Fanti, S., Savelli, G., Romeo, A., Bellanova, B., Rodari, M., van Graafeiland, B. J., Monetti, N., & Bombardieri, E. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050314 · Cited by 168 · cited 5×
“This is slightly higher than those reported in the literature, which vary between 78% and 93%, depending on the different techniques used and the tumors imaged [5, 6, 18, 19, 22, 24].”
BackgroundResultInfluentialTreatment of Metastatic Islet Cell Carcinoma with a Somatostatin Analogue (SMS 201-995)
KVOLS, L. K., BUCK, M., MOERTEL, C. G., SCHUTT, A. J., RUBIN, J., O'CONNELL, M. J., & HAHN, R. G. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-162 · Cited by 168 · cited 1×
“In addition, the absence or presence of in vivo visualization of these tumors after the injection of radiolabeled Octreoscan may predict the ability of octreotide therapy to control symptoms caused by hormonal secretion from these tumors [12, 13].”
BackgroundShi, W. (1998) · QJM · doi:10.1093/qjmed/91.4.295 · Cited by 152 · cited 5×
“This is slightly higher than those reported in the literature, which vary between 78% and 93%, depending on the different techniques used and the tumors imaged [5, 6, 18, 19, 22, 24].”
BackgroundResultInfluentialGastrinomas: comparison of MR imaging with CT, angiography, and US.
Frucht, H., Doppman, J. L., Norton, J. A., Miller, D. L., Dwyer, A. J., Frank, J. A., Vinayek, R., Maton, P. N., & Jensen, R. T. (1989) · Radiology · doi:10.1148/radiology.171.3.2655004 · Cited by 132 · cited 1×
“Several conventional imaging modalities for localizing neuroendocrine tumors have been evaluated, including angiography, ultrasound, CT, and magnetic resonance imaging [5, 10].”
MethodHopper, K. D., Singapuri, K., & Finkel, A. (2000) · Radiology · doi:10.1148/radiology.215.1.r00ap1727 · Cited by 105
Research works printed but not linked: 6
- MB Lobrano, 1997, Am J Gastroenterol, 92, 513
- DJ Kwekkeboom, 1996, J Nucl Med, 37, 886
- SW Lamberts, 1990, Z Gastroenterol, 28, 20
- O Schillaci, 2003, J Nucl Med, 44, 359
- R Lebtahi, 1997, J Nucl Med, 38, 853
- A Oliaro, 1997, J Cardiovasc Surg (Torino), 38, 313
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., & Virgolini, I. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035667 · Cited by 1,010
Sundin, A., Arnold, R., Baudin, E., Cwikla, J. B., Eriksson, B., Fanti, S., Fazio, N., Giammarile, F., Hicks, R. J., Kjaer, A., et al. (2017) · Neuroendocrinology · doi:10.1159/000471879 · Cited by 501
Imaging of Neuroendocrine Tumors
Heller, M. T., & Shah, A. B. (2011) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2011.02.011 · Cited by 329
Sundin, A., Vullierme, M.-P., Kaltsas, G., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000184855 · Cited by 287
Ambrosini, V., Tomassetti, P., Castellucci, P., Campana, D., Montini, G., Rubello, D., Nanni, C., Rizzello, A., Franchi, R., & Fanti, S. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0769-2 · Cited by 266
“However, CT and MRI often have difficulties in correctly separating tumours and mesenterial metastasis from intestinal structures [11, 12] and the low spatial resolution of SRS is a major limit for an accurate identification of NET [13].”
Deppen, S. A., Liu, E., Blume, J. D., Clanton, J., Shi, C., Jones-Jackson, L. B., Lakhani, V., Baum, R. P., Berlin, J., Smith, G. T., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.163865 · Cited by 236
Koopmans, K. P., Neels, O. C., Kema, I. P., Elsinga, P. H., Sluiter, W. J., Vanghillewe, K., Brouwers, A. H., Jager, P. L., & de Vries, E. G. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1126 · Cited by 238
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study
Koopmans, K. P., de Vries, E. G., Kema, I. P., Elsinga, P. H., Neels, O. C., Sluiter, W. J., van der Horst-Schrivers, A. N., & Jager, P. L. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70801-4 · Cited by 237
Schurr, P. G., Strate, T., Rese, K., Kaifi, J. T., Reichelt, U., Petri, S., Kleinhans, H., Yekebas, E. F., & Izbicki, J. R. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000232556.24258.68 · Cited by 178
Multimodal management of neuroendocrine liver metastases
Frilling, A., Sotiropoulos, G. C., Li, J., Kornasiewicz, O., & Plöckinger, U. (2010) · HPB · doi:10.1111/j.1477-2574.2010.00175.x · Cited by 159
“Utilizing advanced CT protocols and fusioning of CT with single positron emission tomography, a sensitivity of 94–100% has been noted.(74,92,93) As an alternative to CT, T2weighted magnetic resonance imaging (MRI) using gadolinium, or in some institutions, mangafodipir trisodium as liver-specific contrast agents is re…”
MethodNeuroendocrine tumours: the role of imaging for diagnosis and therapy
van Essen, M., Sundin, A., Krenning, E. P., & Kwekkeboom, D. J. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.246 · Cited by 148
Imaging in Neuroendocrine Tumors: An Update for the Clinician
Maxwell, J. E., & Howe, J. R. (2015) · International Journal of Endocrine Oncology · doi:10.2217/ije.14.40 · Cited by 142
Etchebehere, E., Santos, A. O., Gumz, B. P., Vicente, A., Hoff, P. G., Corradi, G., Ichiki, W. A., Filho, J. G. D. A., Cantoni, S., Camargo, E. E., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.144543 · Cited by 121
“Prior studies have stated that there are limitations in the detection of hepatic metastases using 68Ga-DOTATATE PETwhereas contrastenhanced CT and MR imaging seem more valuable in this setting (16).”
Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours
Sundin, A. (2012) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2012.12.004 · Cited by 116
Ambrosini, V., Nanni, C., Zompatori, M., Campana, D., Tomassetti, P., Castellucci, P., Allegri, V., Rubello, D., Montini, G. C., Franchi, R., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1349-9 · Cited by 115
68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol
Ruf, J., Schiefer, J., Furth, C., Kosiek, O., Kropf, S., Heuck, F., Denecke, T., Pavel, M., Pascher, A., Wiedenmann, B., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.083741 · Cited by 97
“Although a consensus meeting of experts in the field of NET recently led to the publication of a recommendation to use multiphase CT for imaging of NET (13), data on the value of the different single CT phases are heterogeneous and scarce (14,20,21).”
BackgroundTirosh, A., & Kebebew, E. (2017) · Future Oncology · doi:10.2217/fon-2017-0393 · Cited by 86
International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines
Abib, S. D. C. V., Chui, C. H., Cox, S. G., Abdelhafeez, A. H., Fernández‐Pineda, I., Elgendy, A., Karpelowsky, J. S., Lobos, P. A., Wijnen, M., Fuchs, J., et al. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1356 · Cited by 97
Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET
Fanti, S., Ambrosini, V., Tomassetti, P., Castellucci, P., Montini, G. C., Allegri, V., Grassetto, G., Rubello, D., Nanni, C., & Franchi, R. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.01.010 · Cited by 83
Kos‐Kudła, B., Blicharz-Dorniak, J., Handkiewicz-Junak, D., Jarząb, B., Jarząb, M., Kunikowska, J., Kuśnierz, K., Król, R., Królicki, L., Krzakowski, M. J., et al. (2014) · Endokrynologia Polska · doi:10.5603/ep.2013.0028 · Cited by 70
“The test’s sensitivity in the assessment of hepatic metastases is 82% (78–100%), and specificity is 92% (83–100%) [38, 70, 71].”
BackgroundVersari, A., Camellini, L., Carlinfante, G., Frasoldati, A., Nicoli, F., Grassi, E., Gallo, C., Giunta, F. P., Fraternali, A., Salvo, D., et al. (2010) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3181d6677c · Cited by 71
Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology
Wang, L., Liu, K., Lin, G., & Jiang, T. (2015) · Cancer Imaging · doi:10.1186/s40644-015-0046-0 · Cited by 64
“As PHNET lesions grew in size, the number of intrahepatic lesions increased from single to multiple, focal hemorrhage, necrosis, and portal venous thrombosis became prevalent [15].”
BackgroundRonot, M., Clift, A. K., Baum, R. P., Singh, A., Kulkarni, H., Frilling, A., & Vilgrain, V. (2017) · Neuroendocrinology · doi:10.1159/000479293 · Cited by 65
Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours
Castaldi, P., Rufini, V., Treglia, G., Bruno, I., Perotti, G., Stifano, G., Barbaro, B., & Giordano, A. (2008) · La radiologia medica · doi:10.1007/s11547-008-0319-9 · Cited by 59
Kos‐Kudła, B., Blicharz-Dorniak, J., Strzelczyk, J., Bałdys‐Waligórska, A., Bednarczuk, T., Bolanowski, M., Boratyn-Nowicka, A., Borowska, M., Cichocki, A. S., Ćwikła, J. B., et al. (2017) · Endokrynologia Polska · doi:10.5603/ep.2017.0015 · Cited by 64
Pancreatic neuroendocrine tumors
Sun, J. (2017) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2017.01007 · Cited by 50
Preoperative localization of an insulinoma: selective arterial calcium stimulation test performance
Morera, J., Guillaume, A., Courtheoux, P., Palazzo, L., Rod, A., Joubert, M., & Reznik, Y. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0406-4 · Cited by 43
“Somatostatin receptor (SSTR) scintigraphy (using (111)Inpentetreotide) exhibits low sensitivity (33–50 %) in most series [29, 35, 42], but not in all [43].”
BackgroundPancreatic neuroendocrine tumors: A comprehensive review
Zhou, C., Zhang, J., Zheng, Y. F., & Zhu, Z. (2012) · International Journal of Cancer · doi:10.1002/ijc.27543 · Cited by 47
“CT/MRI are the most common techniques for the diagnosis of pancreatic NET, especially for NF-pancreatic NET, and have sensitivity and specificity >90%.(20) CT/ MRI can also be used for preoperative staging, follow-up and evaluation of treatment efficacy.”
MethodResultGastroenteropancreatic neuroendocrine tumors in children and young adults
Khanna, G., O'Dorisio, M. S., Menda, Y., Kirby, P., Kao, S. C.-S., & Satō, Y. (2007) · Pediatric Radiology · doi:10.1007/s00247-007-0564-4 · Cited by 40
“Multidetector CT Multidetector CT (MDCT) has been shown to have an accuracy of 92% and 96% for the detection of primary tumor and metastasis, respectively [6].”
BackgroundOptimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors
Kunikowska, J., Lewington, V. J., & Królicki, L. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001877 · Cited by 38
Imaging of neuroendocrine gastroenteropancreatic tumours
Graziani, R., Brandalise, A., Bellotti, M., Manfredi, R. M., Contro, A., Falconi, M., Boninsegna, L., & Mucelli, R. P. (2010) · La radiologia medica · doi:10.1007/s11547-010-0540-1 · Cited by 35
Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors
Maxwell, J. E., O’Dorisio, T. M., & Howe, J. R. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.08.008 · Cited by 32
Koffas, A., Giakoustidis, A. E., Papaefthymiou, A., Bangeas, P., Giakoustidis, D. E., Papadopoulos, V. N., & Toumpanakis, C. (2023) · Frontiers in Surgery · doi:10.3389/fsurg.2023.1064145 · Cited by 33
Aace/Ace Disease State Clinical Review: Diagnosis and Management of Midgut Carcinoids
Liu, E. H., Solórzano, C. C., Katznelson, L. J., Vinik, A. I., Wong, R. J., & Randolph, G. W. (2015) · Endocrine Practice · doi:10.4158/ep14464.dsc · Cited by 29
Zhu, C. Y., XIAO, H.-E., RAMCHANDRA, P., & HUANG, H.-J. (2014) · Oncology Letters · doi:10.3892/ol.2014.1844 · Cited by 29
“These results are consistent with previous observations (15,16).”
ResultTreatment of advanced disease in patients with well-differentiated neuroendocrine tumors
Reidy‐Lagunes, D. L., Tang, L. H., & Saltz, L. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/ncponc1326 · Cited by 29
“Although this technique is often used for this purpose, the incidence of tumors that are undetected by modern CT and MRI, and then detected by 111 In pentetreotide scintigraphy, in order to change a patient's therapy, is really quite low”
MethodManguso, N., Gangi, A., Johnson, J. E., Harit, A. P., Nissen, N. N., Jamil, L. H., Lo, S. K., Wachsman, A. M., Hendifar, A. E., & Amersi, F. F. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24825 · Cited by 28
“Other studies report thedetection rateand sensitivity of CT, MRI, and SRI are similar and should be used as complimentary studies.(13,27,28,32) Our findings demonstrate no significant difference between these modalities in either identification of the primary lesion or multi-focal disease.”
ResultEndoscopic ultrasound and neuroendocrine tumours of the pancreas.
Fritscher‐Ravens, A. (2004) · PubMed · Cited by 28
Sadigh, G., Applegate, K. E., & Baumgarten, D. A. (2013) · Academic Radiology · doi:10.1016/j.acra.2013.08.023 · Cited by 24
Grimaldi, F., Fazio, N., Attanasio, R., Frasoldati, A., Papini, E., Angelini, F., Baldelli, R., Berretti, D., Bianchetti, S., Bizzarri, G., et al. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0119-0 · Cited by 23
“Reported mean sensitivity and specificity of MDCT are 73 % (63–82 %) and 96 % (83–100 %) for pNENs, and 82 % (78–100 %) and 92 % (83–100 %) for liver metastases, respectively [104–106].”
BackgroundStawarski, A., & Maleika, P. (2020) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/111806 · Cited by 20
PET/CT using 18F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting
Yakemchuk, V. N., Jager, P. L., Chirakal, R. V., Reid, R. H., Major, P. P., & Gulenchyn, K. Y. (2011) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32834f2603 · Cited by 16
Multimodality Imaging of Neuroendocrine Tumors
Galgano, S. J., Sharbidre, K., & Morgan, D. E. (2020) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2020.07.008 · Cited by 15
Hyperammonemic encephalopathy in a patient with primary hepatic neuroendocrine carcinoma
Türken, O., Başekim, C. Ç., Haholu, A., Karagöz, B., Bilgi, O., Ozgun, A., Küçükardalı, Y., Narin, Y., Yazgan, Y., & Kandemir, E. G. (2008) · Medical Oncology · doi:10.1007/s12032-008-9121-8 · Cited by 14
“Most of primary and metastatic neuroendocrine tumors can be diagnosed by CT or magnetic resonance imaging (MRI) just because the most important characteristic of these tumors is hypervascularity [ 19 ].”
BackgroundÖrlefors, H., Sundin, A., Eriksson, B. K., Skogseid, B. M., Öberg, K., Åkerström, G., & Hellman, P. (2012) · Cancers · doi:10.3390/cancers4010100 · Cited by 13
“Anatomical imaging by computed tomography (CT) and magnetic resonance imaging (MRI) still forms the basis for tumour visualization, but cannot always visualize smaller tumours [6,7].”
MethodTian, B., Yang, M., Zhang, Y., Su, A., Yue, P., Xu, S., & Wang, L. (2015) · Indian Journal of Cancer · doi:10.4103/0019-509x.176746 · Cited by 11
McDermott, S., O’Neill, A. C., & Skehan, S. J. (2012) · Clinical Imaging · doi:10.1016/j.clinimag.2012.05.006 · Cited by 10
“Extrahepatic metastases In a study comparing the accuracy of helical CT versus SRS in imaging of neuroendocrine tumors in 27 patients, the sensitivity, specificity and accuracy of diagnosing extrahepatic metastases was 100%, 100% and 100% for CT and 50%, 94% and 78% for SRS, respectively [27].”
BackgroundImaging of neuroendocrine tumors
Sundin, A. (2012) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2012.692874 · Cited by 9
Megibow, A. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-2332-6.50105-6 · Cited by 10
Banzo, J., Pratsa, E., Razola, P., García, S., Alonso, V., Velilla, J., Freile, E., Benito, J. L., García, F., Ubieto, M. Á., et al. (2005) · Revista Española de Medicina Nuclear · doi:10.1157/13076648 · Cited by 7
Akabane, M., Kobayashi, Y., Kinowaki, K., Okubo, S., Shindoh, J., & Hashimoto, M. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i7.2222 · Cited by 6
NEN: Advancement in Diagnosis and Minimally Invasive Therapy
Putzer, D., Schullian, P., Jaschke, W. R., & Bale, R. J. (2019) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-1030-4631 · Cited by 6
Jilesen, A. P. J., Hoefnagel, S. J. M., Busch, O. R., Bennink, R. J., Gouma, D. J., & van Dijkum, E. J. M. N. (2016) · Clinical Radiology · doi:10.1016/j.crad.2016.01.015 · Cited by 5
Update Regarding Imaging of Neuroendocrine Neoplasms
Figiel, J. H., Viniol, S., Görlach, J., Rinke, A., Librizzi, D., & Mahnken, A. H. (2019) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-1001-2412 · Cited by 6
Hiperinsulinismo endógeno: revisão e seguimento de 24 casos
Felício, J. S., Martins, C. L. E. L. P., Semer, M., Kalinin, L. B., Nery, M., Machado, M. C. C., & Liberman, B. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000200001 · Cited by 7
Cryer, P. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00034-1 · Cited by 7
Molecular Imaging of Neuroendocrine Cancer by Fusion SPET/CT
Alberini, J., Wartski, M., Edeline, V., Madar, O., Banayan, S., Bellet, D. H., & Pecking, A. P. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-087-8_15 · Cited by 3
Xue, H., Liu, W., Sun, H., Merges, R. D., Wang, X., Zhang, X., Wang, Y., Zhao, W., Chen, J., & Jin, Z. (2008) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(09)60001-8 · Cited by 3
Neuroendocrine Tumours of the Pancreas
BHANDARE, M. S., Gupta, V. K., Chaudhari, V. A., & Shrikhande, S. V. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780192858443.003.0011 · Cited by 2
Strate, T. G., Schurr, P., & Izbicki, J. R. (2007) · Visceral Medicine · doi:10.1159/000100423 · Cited by 2
SPECT/CT with 99mTc-Tectrotide in the diagnosis of insulinoma
Yukina, M. Y., Troshina, E. A., Nuralieva, N. F., Degtyarev, M. V., & Mokrysheva, N. G. (2023) · Obesity and metabolism · doi:10.14341/omet12977 · Cited by 3
Unusual Tumors of the Colon, Rectum, And Anus
Reidy‐Lagunes, D. L., Goodman, K. A., & Saltz, L. B. (2012) · Wiley eBooks · doi:10.1002/9781118464557.ch32 · Cited by 1
Multimodal imaging in functional endocrine pancreatic tumors
Müssig, K., Bares, R., Erckenbrecht, J. F., & Horger, M. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.57 · Cited by 1
Insulinoma Manifesting Early Postpartum: Case Report and Review of the Literature
Gertje, E. C., Walenkamp, A., Glaudemans, A. W. J. M., Ijtsma, S. A. J. C., Hoogenberg, K., & Dullaart, R. P. F. (2015) · AACE Clinical Case Reports · doi:10.4158/ep14549.cr · Cited by 2
Imagerie des métastases hépatiques
Luciani, A., Jourdan, G., Itti, E., Nhieu, J. T. V., Djabbari, M., Zegai, B., Karoui, M., Anglade, M. C., & Rahmouni, A. (2007) · EMC - Radiologie et imagerie médicale - Abdominale - Digestive · doi:10.1016/s1879-8527(07)72818-6 · Cited by 1
Positron emission tomography in the diagnosis and staging of pancreatic and neuroendocrine tumors
Kauhanen, S. P. (2009) · UTUPub (University of Turku) · Cited by 1
Tracer development for detection and characterization of neuroendocrine tumors with PET
Neels, O. C. (2008) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Ligand-Directed AAVP to Deliver a Therapeutic Transgene to Neuroendocrine Tumors of the Pancreas
Smith, T. L. (2013) · Digital Commons-TMC (Texas Medical Center)
SPECT/CT, and Whole-Body MR Imaging in Detection of Neuroendocrine Tumors: A Prospective Trial
Cristina, E., Etchebehere, S. D. C., Santos, A. D., Gumz, B. P., Vicente, A., GhemHoff, P., Corradi, G., Ichiki, W. A., Filho, J. O. G. D. A., Cantoni, S., et al. (2014)
Grimaldi, F., Fazio, N., Attanasio, R., Frasoldati, A., Zini, M., Nuova, S. M., Papini, E., Angelini, F., Bianchetti, S., Baldelli, R., et al. (2014)
A Case of Insulinoma With Provoked Seizures for the Past Fourteen Years: A Case Report
kadkhodazadeh, H., Kazempour, M., & Salevatipour, B. (2015) · Archives of Critical Care Medicine · doi:10.17795/accm-7511
“Endoscopic pancreatic ultrasonography (EUS), with the option of fine-needle aspiration of a detected tumor, has a sensitivity of greater than 90% (7, 8).”
BackgroundRole of Non-Functional Imaging in the Diagnosis of Abdominal Neuroendocrine Tumors
Zerunian, M., Bellini, D., & Laghi, A. (2017) · Updates in surgery/Updates in surgery series · doi:10.1007/978-88-470-3955-1_7
Advances in the Diagnosis and Management of Nonfunctional Pancreatic Neuroendocrine Tumors
Laird, A. M., & Libutti, S. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66195-9.00020-0
Imaging of Neuroendocrine Tumors
Mirpour, S., Ghadimi, M., Pawlik, T. M., & Kamel, I. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-62241-1_2
Self-citationRecurrence rate of superficial bladder cancer with intravesical BCG and mitomycin.
Hussain, K., Asif, M. K., Malik, F., Yasmeen, M., Tariq, M., & Khan, A.-U.-R. (2021) · The Professional Medical Journal · doi:10.29309/tpmj/2021.28.06.4968
Neuroendocrine Tumor III — Gastrinoma Liver Metastases
(2007) · Springer eBooks · doi:10.1007/978-3-540-68239-4_30
Fanti, S., & Maffione, A. M. (2012) · Springer eBooks · doi:10.1007/978-0-387-48894-3_17
Unusual Tumors of the Colon, Rectum, and Anus
Reidy‐Lagunes, D. L., Lieu, C. H., Messersmith, W. A., & Goodman, K. A. (2017) · Wiley eBooks · doi:10.1002/9781119196235.ch31
Milla, S. S., & Bixby, S. D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6206-6.10095-1
Radiological Diagnosis of Pancreatic Neuroendocrine Neoplasms
Fugazzola, C., Angeretti, M. G., Lucchina, N., Duka, E., Molinelli, V., & Sessa, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-17235-4_2
“As concerns extrahepatic metastases , contrastenhanced MDCT of the thorax, abdomen, and pelvis can be used [ 101 ]; additional imaging with other modalities such as MRI of the spine may be necessary for characterization of nonspecifi c abnormalities identifi ed on CT.”
Method
Metadata
- Authors
- Kumbasar, B., Kamel, I. R., Tekes, A., Eng, J., Fishman, E. K., & Wahl, R. L.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Abdominal Imaging
- Published
- 2004-05-27
- Volume
- 29
- Issue
- 6
- Pages
- 696-702
- ISSN
- 0942-8925 (ISSN-L)
- 1432-0509
- OpenAlex
- W1968601682
- Semantic Scholar
- f5de589f591f4b1c195638170a47e62c80db30ff
- Cited by
- 84
- References
- 28
- Citations by year
- 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3 · 2017: 9 · 2016: 2 · 2015: 10 · 2014: 6 · 2013: 3 · 2012: 10
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Abdominal Imaging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- neuroendocrine tumors, spiral CT, somatostatin receptor scintigraphy, metastasis detection, liver metastasis, extrahepatic metastasis, primary tumor site, diagnostic accuracy, sensitivity and specificity
- MeSH terms
- Adolescent, Adult, Aged, Female, Humans, Indium Radioisotopes, Intestinal Neoplasms, Adenoma, Islet Cell, Liver Neoplasms, Male, Middle Aged, Pancreatic Neoplasms, Radionuclide Imaging, Sensitivity and Specificity, Somatostatin, Receptors, Somatostatin, Neuroendocrine Tumors, Tomography, Spiral Computed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.